Ratings Summary for NASONEX

Overall Patient opinion of NASONEX: 2.0 (not satisfied)

(based on 1129 reviews ) (updated May 6, 2025)

Ratings by Age Group for NASONEX
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	101	1.8
Age 18 to 24	78	2.3
Age 25 to 34	238	2.3
Age 35 to 44	269	2.0
Age 45 to 54	245	2.1
Age 55 to 64	120	1.9
Age 65 to 74	40	2.1
Age 75 and up	6	1.8

Ratings by Sex for NASONEX
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	442	2.20135746606335
Female	661	2.00605143721634
Not Specified	24	2.79166666666667

Would you like to find reviews for NASONEX taken for a specific reason or resulting in a specific side effect?

Filter Results for NASONEX

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for NASONEX

Check here for Ask a Patient's Adverse Event Summary for NASONEX based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

NASONEX (MOMETASONE FUROATE MONOHYDRATE): Mometasone is used to prevent and treat seasonal and year-round allergy symptoms (such as stuffy/runny nose, itching, and sneezing). It is also used to treat certain growths in the nose (nasal polyps). Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages. FDA Approval Date: 1997-10-01 (Sources: U.S. Centers for Medicare Services, FDA)